|
 |
| home > directory > Domino UK Ltd |
|
|
 PHARMACEUTICAL INDUSTRY DIRECTORY |
Domino UK Ltd |
 |
|
Founded in 1978 and headquartered in Cambridge, UK, Domino Printing Sciences plc is a world-leader in providing total coding, marking, printing, traceability and RFID solutions. Through constant product development and acquisition, Domino now offers complete end to end solutions incorporating primary, secondary and tertiary applications.
The company has established a global reputation for innovative ink jet, laser, print & apply and thermal transfer overprinting technologies for the application of variable data, bar codes and unique traceability codes onto products and packaging in industries such as food, beverage, construction and pharmaceutical.
In 2006 Domino had a turnover in excess of £208M. It employs 1,800 people worldwide and sells to more than 120 countries through a global network of 16 subsidiary offices and more than 75 distributors. Domino's manufacturing facilities are situated in China, Germany, India, UK and USA.
Domino Integrated Solutions Group
Domino’s Integrated Solutions Group is a leading innovator of technologies and solutions that provide full traceability and product security systems ranging from initial needs-based consultation, technology evaluation and testing through to full systems implementation.
The successful integration of RFID and its inter-operability with common alpha/numeric and 2D codes is central to Domino’s total systems/open platform approach. By integrating leading AIDC (automatic identification and data capture) technologies, combined with powerful data management platforms, Domino delivers bespoke, scaleable track and trace solutions embracing every stage of the supply chain. |
|
|
|
|
|
 |
|
|
|
 |
Industry Events |
 |
EuroBiopartnering 2008
7-9 October 2008, Paris, France
EuroBiOpartnering
2008 gives you the unique opportunity to meet the relevant decision makers and
opinion leaders from the international biotech community and offers you 3 days
of partnering opportunities including one-to-one meetings, company presentations
and further networking activities…
More info >> |
|
 |
News and Press Releases |
 |
Azopharma Announces Plans to Implement XcelodoseTM Technology in the Production of Early Stage Clinical Trial Materials
HOLLYWOOD, Fla. – Azopharma Product Development Group, Inc. (“Azopharma”) announced today plans to implement Xcelodose technology at its formulations development facility, ApiCross Drug Delivery Technologies. Xcelodose technology is a powder micro-dosing system developed by Meridica. This technology offers a unique powder dispensing system for small-scale capsule filling and ultimately assists in conserving valuable research material as well as reducing various Preformulation activities.
More info >> |
|
 |
|
